UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 67 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 66 | +2100.0% | 0.00% | – |
| Q2 2022 | $0 | – | 3 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 3 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 3 | -100.0% | 0.00% | – |
| Q3 2021 | $258,000 | -66.0% | 85,820 | -47.5% | 0.00% | – |
| Q2 2021 | $758,000 | +2.6% | 163,324 | +32.7% | 0.00% | – |
| Q1 2021 | $739,000 | +36.1% | 123,063 | +18.6% | 0.00% | – |
| Q4 2020 | $543,000 | +1106.7% | 103,725 | +698.4% | 0.00% | – |
| Q3 2020 | $45,000 | -93.9% | 12,991 | -84.7% | 0.00% | – |
| Q2 2020 | $735,000 | +1286.8% | 84,702 | +827.7% | 0.00% | – |
| Q1 2020 | $53,000 | -32.9% | 9,130 | -16.6% | 0.00% | – |
| Q4 2019 | $79,000 | +25.4% | 10,942 | +5.5% | 0.00% | – |
| Q3 2019 | $63,000 | -8.7% | 10,375 | +25.7% | 0.00% | – |
| Q2 2019 | $69,000 | +21.1% | 8,256 | +18.0% | 0.00% | – |
| Q1 2019 | $57,000 | -51.7% | 6,997 | -3.9% | 0.00% | – |
| Q4 2018 | $118,000 | +247.1% | 7,283 | +247.8% | 0.00% | – |
| Q3 2018 | $34,000 | +126.7% | 2,094 | +104.3% | 0.00% | – |
| Q2 2018 | $15,000 | – | 1,025 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund V Management, LLC | 491,751 | $275,000 | 2.22% |
| GSA CAPITAL PARTNERS LLP | 639,937 | $361,000 | 0.05% |
| PURA VIDA INVESTMENTS, LLC | 359,089 | $202,000 | 0.01% |
| Caption Management, LLC | 725,000 | $409,000 | 0.01% |
| Forefront Analytics, LLC | 20,377 | $11,000 | 0.01% |
| Johnson Midwest Financial, LLC | 6,100 | $3,000 | 0.00% |
| Virtu Financial LLC | 62,640 | $35,000 | 0.00% |
| Caption Management, LLC | 225,000 | $127,000 | 0.00% |
| SeaCrest Wealth Management, LLC | 25,000 | $14,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 191,450 | $108,000 | 0.00% |